Idera

Idera Pharmaceuticals is a biotechnology company that discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, asthma and allergies, as well as for use as vaccine adjuvants. The company designs and creates proprietary Toll-like receptors (TLRs) to modulate immune responses, including TLR agonists (compounds that stimulate immune responses by targeting TLRs) and TLR antagonists (compounds that block immune response activation by targeting TLRs).